Cadilas Dabhasa facility receives Establishment Inspection Report

Cadilas Dabhasa facility receives Establishment Inspection Report

Dec 06, 2019 09:12 IST capital market

Cadila Healthcare announced that the companys API manufacturing facility located at Dabhasa, Gujarat has received an Establishment Inspection Report (EIR). The USFDA had conducted an inspection at the facility from 7 to 11 October 2019. The EIR report stated that the classification of the facility is No Action Indicated (NAI).

Powered by Capital Market - Live News

Related Story